10-Q Filing

SWK Holdings Corp CIK: 1089907 Q2 2023

Filing Information

Form Type	10-Q
Accession Number	`0001552781-23-000359`
Period End Date	20230630
Filing Date	20230810
Fiscal Year	2023
Fiscal Period	Q2
XBRL Instance	e23352_swkh-10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 78 Income Statement 80 Cash Flow Statement 72 Stockholders Equity 30

Balance Sheet 78 line items

Line Item	Tag	Value	Unit	Period
Financing Receivable, Allowance for Credit Loss	`FinancingReceivableAllowanceForCreditLosses`	$11.10M	USD	Point-in-time
Financing Receivable, Allowance for Credit Loss	`FinancingReceivableAllowanceForCreditLosses`	$8.39M	USD	Point-in-time
Financing Receivable, Allowance for Credit Loss	`FinancingReceivableAllowanceForCreditLosses`	$11.85M	USD	Point-in-time
Financing Receivable, Allowance for Credit Loss	`FinancingReceivableAllowanceForCreditLosses`	$8.37M	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.16M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$42.86M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.80M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$55.12M	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Interest and accounts receivable, net	`AccountsReceivableNet`	$3.09M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Interest and accounts receivable, net	`AccountsReceivableNet`	$4.38M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.89M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.11M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$10.36M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$13.07M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Finance receivables, net of allowance for credit losses of $11,104 and $11,846, as of June 30, 2023 and December 31, 2022, respectively	`NotesAndLoansReceivableNetCurrent`	$222.95M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Finance receivables, net of allowance for credit losses of $11,104 and $11,846, as of June 30, 2023 and December 31, 2022, respectively	`NotesAndLoansReceivableNetCurrent`	$236.56M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	12.57M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	12.84M	shares	Point-in-time
Collateral on foreign currency forward contract	`DerivativeInstrumentsAndHedges`	$2.75M	USD	Point-in-time
Collateral on foreign currency forward contract	`DerivativeInstrumentsAndHedges`	$2.75M	USD	Point-in-time
Marketable investments	`AvailableForSaleSecuritiesDebtSecurities`	$59.00K	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	12.57M	shares	Point-in-time
Marketable investments	`AvailableForSaleSecuritiesDebtSecurities`	$76.00K	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	12.84M	shares	Point-in-time
Deferred tax assets, net	`DeferredIncomeTaxAssetsNet`	$25.69M	USD	Point-in-time
Deferred tax assets, net	`DeferredIncomeTaxAssetsNet`	$24.48M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$1.22M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$1.46M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$8.19M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$7.34M	USD	Point-in-time
Goodwill	`Goodwill`	$8.40M	USD	Point-in-time
Goodwill	`Goodwill`	$8.40M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.60M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.84M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$1.74M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$3.12M	USD	Point-in-time
Total assets	`Assets`	$299.62M	USD	Point-in-time
Total assets	`Assets`	$290.44M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.90M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.00M	USD	Point-in-time
Revolving credit facility	`LinesOfCreditCurrent`	$2.44M	USD	Point-in-time
Revolving credit facility	`LinesOfCreditCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.35M	USD	Point-in-time
Contingent consideration payable	`BusinessCombinationContingentConsiderationLiability`	$11.20M	USD	Point-in-time
Contingent consideration payable	`BusinessCombinationContingentConsiderationLiability`	$11.20M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$2.36M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$2.15M	USD	Point-in-time
Total liabilities	`Liabilities`	$16.56M	USD	Point-in-time
Total liabilities	`Liabilities`	$19.69M	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,566,519 and 12,843,157 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,566,519 and 12,843,157 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.43B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.43B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.15B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.15B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$270.80M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$267.24M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$279.93M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$274.38M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$273.88M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$271.53M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$290.44M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$299.62M	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$18.54M	USD	2 Qtrs
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$6.83M	USD	1 Quarter
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$9.28M	USD	1 Quarter
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$17.24M	USD	2 Qtrs
Pharmaceutical development	`PharmaceuticalDevelopmentRevenue`	$183.00K	USD	1 Quarter
Pharmaceutical development	`PharmaceuticalDevelopmentRevenue`	$350.00K	USD	2 Qtrs
Pharmaceutical development	`PharmaceuticalDevelopmentRevenue`	$301.00K	USD	2 Qtrs
Pharmaceutical development	`PharmaceuticalDevelopmentRevenue`	$114.00K	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomerOther`	$69.00K	USD	2 Qtrs
Other	`RevenueNotFromContractWithCustomerOther`	$36.00K	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomerOther`	$480.00K	USD	2 Qtrs
Other	`RevenueNotFromContractWithCustomerOther`	-	USD	1 Quarter
Total revenues	`Revenues`	$18.07M	USD	2 Qtrs
Total revenues	`Revenues`	$6.94M	USD	1 Quarter
Total revenues	`Revenues`	$18.91M	USD	2 Qtrs
Total revenues	`Revenues`	$9.50M	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	-	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$-682.00K	USD	2 Qtrs
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	-	USD	2 Qtrs
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$-682.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$80.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$363.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$545.00K	USD	2 Qtrs
Interest expense	`InterestExpense`	$160.00K	USD	2 Qtrs
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$1.51M	USD	1 Quarter
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$3.38M	USD	2 Qtrs
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$1.48M	USD	1 Quarter
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$2.23M	USD	2 Qtrs
Depreciation and amortization expense	`DepreciationAndAmortization`	$1.28M	USD	2 Qtrs
Depreciation and amortization expense	`DepreciationAndAmortization`	$626.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationAndAmortization`	$1.33M	USD	2 Qtrs
Depreciation and amortization expense	`DepreciationAndAmortization`	$637.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$5.54M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.02M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$6.18M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.00M	USD	1 Quarter
Income from operations	`CostsAndExpenses`	$-9.99M	USD	2 Qtrs
Income from operations	`CostsAndExpenses`	$-1.74M	USD	1 Quarter
Income from operations	`CostsAndExpenses`	$-7.02M	USD	2 Qtrs
Income from operations	`CostsAndExpenses`	$-4.67M	USD	1 Quarter
Unrealized net gain (loss) on warrants	`UnrealizedGainLossOnDerivatives`	$-583.00K	USD	2 Qtrs
Unrealized net gain (loss) on warrants	`UnrealizedGainLossOnDerivatives`	$399.00K	USD	1 Quarter
Unrealized net gain (loss) on warrants	`UnrealizedGainLossOnDerivatives`	$-1.17M	USD	2 Qtrs
Unrealized net gain (loss) on warrants	`UnrealizedGainLossOnDerivatives`	$-472.00K	USD	1 Quarter
Unrealized net loss on equity securities	`MarketableSecuritiesUnrealizedGainLoss`	$-519.00K	USD	1 Quarter
Unrealized net loss on equity securities	`MarketableSecuritiesUnrealizedGainLoss`	-	USD	2 Qtrs
Unrealized net loss on equity securities	`MarketableSecuritiesUnrealizedGainLoss`	$-547.00K	USD	2 Qtrs
Unrealized net loss on equity securities	`MarketableSecuritiesUnrealizedGainLoss`	-	USD	1 Quarter
Gain on foreign currency transactions	`ForeignCurrencyTransactionGainBeforeTax`	-	USD	2 Qtrs
Gain on foreign currency transactions	`ForeignCurrencyTransactionGainBeforeTax`	$316.00K	USD	1 Quarter
Gain on foreign currency transactions	`ForeignCurrencyTransactionGainBeforeTax`	-	USD	1 Quarter
Gain on foreign currency transactions	`ForeignCurrencyTransactionGainBeforeTax`	$502.00K	USD	2 Qtrs
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$5.31M	USD	2 Qtrs
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$747.00K	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$5.39M	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$9.91M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$182.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$1.27M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$1.34M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$1.45M	USD	1 Quarter
Net income	`ProfitLoss`	$565.00K	USD	1 Quarter
Net income	`ProfitLoss`	$4.04M	USD	2 Qtrs
Net income	`ProfitLoss`	$8.57M	USD	2 Qtrs
Net income	`ProfitLoss`	$3.93M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.04	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.32	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$0.67	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$0.31	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.31	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.67	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.04	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.31	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.83M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.84M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.74M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.79M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.88M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.88M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.83M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.79M	shares	1 Quarter

Cash Flow Statement 72 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$565.00K	USD	1 Quarter
Net income	`ProfitLoss`	$4.04M	USD	2 Qtrs
Net income	`ProfitLoss`	$8.57M	USD	2 Qtrs
Net income	`ProfitLoss`	$3.93M	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	-	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$-682.00K	USD	2 Qtrs
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	-	USD	2 Qtrs
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$-682.00K	USD	1 Quarter
Right-of-use asset amortization	`FinanceLeaseRightOfUseAssetAmortization`	$113.00K	USD	2 Qtrs
Right-of-use asset amortization	`FinanceLeaseRightOfUseAssetAmortization`	$156.00K	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$29.00K	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$168.00K	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$1.26M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$1.32M	USD	2 Qtrs
Change in fair value of warrants	`FairValueAdjustmentOfWarrants`	$1.17M	USD	2 Qtrs
Change in fair value of warrants	`FairValueAdjustmentOfWarrants`	$583.00K	USD	2 Qtrs
Change in fair value of equity securities	`MarketableSecuritiesUnrealizedGainLoss`	$-519.00K	USD	1 Quarter
Change in fair value of equity securities	`MarketableSecuritiesUnrealizedGainLoss`	-	USD	2 Qtrs
Change in fair value of equity securities	`MarketableSecuritiesUnrealizedGainLoss`	$-547.00K	USD	2 Qtrs
Change in fair value of equity securities	`MarketableSecuritiesUnrealizedGainLoss`	-	USD	1 Quarter
Foreign currency transaction gain	`ForeignCurrencyTransactionGainLossBeforeTax`	$-516.00K	USD	2 Qtrs
Foreign currency transaction gain	`ForeignCurrencyTransactionGainLossBeforeTax`	-	USD	2 Qtrs
Loan discount and fee accretion	`AmortizationOfDeferredLoanOriginationFeesNet`	$2.30M	USD	2 Qtrs
Loan discount and fee accretion	`AmortizationOfDeferredLoanOriginationFeesNet`	$780.00K	USD	2 Qtrs
Interest paid-in-kind	`PaidInKindInterest`	$1.60M	USD	2 Qtrs
Interest paid-in-kind	`PaidInKindInterest`	$957.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$35.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$199.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$166.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$251.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$164.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$85.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.28M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.33M	USD	2 Qtrs
Interest and accounts receivable	`IncreaseDecreaseInInterestAndDividendsReceivable`	$1.29M	USD	2 Qtrs
Interest and accounts receivable	`IncreaseDecreaseInInterestAndDividendsReceivable`	$66.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$792.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$256.00K	USD	2 Qtrs
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-2.53M	USD	2 Qtrs
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-357.00K	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$3.51M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$5.39M	USD	2 Qtrs
Proceeds from sale of investments	`ProceedsFromSaleOfEquityMethodInvestments`	-	USD	2 Qtrs
Proceeds from sale of investments	`ProceedsFromSaleOfEquityMethodInvestments`	$13.94M	USD	2 Qtrs
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$13.10M	USD	2 Qtrs
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$25.35M	USD	2 Qtrs
Repayment of finance receivables	`ProceedsRepaymentOfFinanceReceivables`	$34.20M	USD	2 Qtrs
Repayment of finance receivables	`ProceedsRepaymentOfFinanceReceivables`	$3.04M	USD	2 Qtrs
Corporate debt securities principal payments	`MarketableInvestmentPrincipalPayment`	$17.00K	USD	2 Qtrs
Corporate debt securities principal payments	`MarketableInvestmentPrincipalPayment`	$21.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$111.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$191.00K	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$3.71M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$8.76M	USD	2 Qtrs
Payments for financing costs	`PaymentsOfFinancingCosts`	-	USD	2 Qtrs
Payments for financing costs	`PaymentsOfFinancingCosts`	$872.00K	USD	2 Qtrs
Net payments on credit facility	`ProceedsFromRepaymentsOfLinesOfCredit`	$-2.44M	USD	2 Qtrs
Net payments on credit facility	`ProceedsFromRepaymentsOfLinesOfCredit`	$-8.00K	USD	2 Qtrs
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	-	USD	2 Qtrs
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	$5.13M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-8.00K	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-8.45M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$649.00K	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$12.26M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$6.16M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$42.86M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$6.80M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$55.12M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$6.16M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$42.86M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$6.80M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$55.12M	USD	Point-in-time

Stockholders Equity 30 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$270.80M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$267.24M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$279.93M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$274.38M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$273.88M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$271.53M	USD	Point-in-time
Stock-based compensation	`ShareBasedCompensation`	$35.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$199.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$166.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$251.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$164.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$85.00K	USD	1 Quarter
Effect of adoption of ASC 326	`EffectOfAdoptionOfAccountingStandard`	$-9.68M	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Repurchase of common stock in open market	`StockRepurchasedDuringPeriodValue`	$531.00K	USD	1 Quarter
Repurchase of common stock in open market	`StockRepurchasedDuringPeriodValue`	$4.60M	USD	1 Quarter
Net income	`NetIncomeLoss`	$4.63M	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.93M	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.48M	USD	1 Quarter
Net income	`NetIncomeLoss`	$565.00K	USD	1 Quarter
Forfeiture of unvested restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures`	-	USD	1 Quarter
Ending balance, value	`StockholdersEquity`	$270.80M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$267.24M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$279.93M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$274.38M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$273.88M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$271.53M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.